Robert Olstein's TMO Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 8.0K shares of Thermo Fisher Scientific Inc. (TMO) worth $3.88 M, representing 0.73% of the portfolio. First purchased in 2017-Q2, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Robert Olstein has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1.0K shares. Largest reduction occurred in Q4 2018, reducing 9.5K shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Robert Olstein
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2017 | +23,000 | New Buy | 23,000 | $174.48 |
| Q3 2018 | -1,000 | Reduce 4.35% | 22,000 | $244.09 |
| Q4 2018 | -9,500 | Reduce 43.18% | 12,500 | $223.76 |
| Q1 2019 | -500 | Reduce 4.00% | 12,000 | $273.75 |
| Q2 2019 | -1,500 | Reduce 12.50% | 10,500 | $293.71 |
| Q4 2019 | -1,000 | Reduce 9.52% | 9,500 | $324.84 |
| Q2 2020 | -2,500 | Reduce 26.32% | 7,000 | $362.29 |
| Q3 2020 | -7,000 | Sold Out | 7,000 | $0.00 |
| Q2 2025 | +8,000 | New Buy | 8,000 | $405.50 |
Robert Olstein's Thermo Fisher Scientific Investment FAQs
Robert Olstein first purchased Thermo Fisher Scientific Inc. (TMO) in Q2 2017, acquiring 23,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Thermo Fisher Scientific Inc. (TMO) for 34 quarters since Q2 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2017, adding 23,000 shares worth $4.01 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 8,000 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $3.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.73% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's peak holding in Thermo Fisher Scientific Inc. (TMO) was 23,000 shares, as reported at the end of Q2 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.